secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lantern Pharma Inc. (LTRN)
CIK:        0001763950
Form:       8-K
Filed at:   2026-09-23T11:45:18+00:00
Accession:  0001493152-26-043808
Event type: other_material
Sentiment:  positive
Materiality: 0.45
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lantern Pharma to present Open-Medicine AI growth plan in live webinar today
----------------------------------------------------------------------------

- Webinar at 12:30 PM ET led by CEO Panna Sharma covering OMAI market, roadmap, economics, benchmarks, partnerships.
- OMAI launched as withZeta.ai in April 2026 for rare cancers; ZetaOmics module added July 2026 for early-access users.
- Platform monetized via subscription and enterprise licensing to biopharma, research institutions, and drug developers.
- Session to include live demo, user feedback, key milestones, and shareholder-value discussion; replay available post-event.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1763950/000149315226043808/0001493152-26-043808-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1763950/000149315226043808/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-043808

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer